Socios de Colaboración

Consorcios y Redes científicas 

MEDINA forma parte de diferentes consorcios y redes científicas de investigación subvencionados por programas nacionales y europeos.

pharmasea
bluegreen
microsmetics
paramet
ricet
ocean medicines
logomarpipe
TOPCAPIlogo2-150x150
logoiimena2
imi4nnb
logo

Colaboraciones

granada
SCIC2
pablo

La Fundación colabora activamente con organizaciones nacionales e internacionales que incluyen universidades, institutos de investigación y empresas privadas.

universidadsevilla
uni madrid
bcn
jaen
alcala
oviedo
salamanca
isciii3
ibs
ciberer
ceibiotic
ceu
cnio
vhio2
mac
reipi
ndpi
hki
ibis2
vib
pasteur
henry ford 4
sidney
dtu3
chicago
nice
mc master
cycleniumweb
abacweb
iden
descarga
eligochemweb

Afiliaciones

sem
asebio
european biotec

We are corporate members of national & international scientific societies and biotech sector associations. 

sebbmm


Proyectos

EU-OPENSCREEN DRIVE - Development and long-term sustainability of new pan-European research infrastructures

Grant Agreement No.: 823893

EU-OS-DRIVE aims to accelerate the implementation of EU-OS and promote the early utilization of the RI. The project will support the implementation of the EU-OS scientific and technical program and the delivery of its main mission: to build a sustainable European infrastructure for chemical biology, supporting life-science research with innovative chemical tools and bioactivity data and the translation to society, environment and medicine.

https://www.eu-openscreen.eu/

IIMENA - Integration of Informatics and Metabolomic Engineering for the discovery of Novels Antibiotics

Funded by the Novo Nordisk Foundation. Duration: 2017 - 2023

The iimena-project aims to integrate state-of-the art screening technologies, bioinformatics and metabolic engineering approches in order to identify and characterize novel secondary metabolites from actinomycetes, which can become lead-candidates for antibiotic drug development.

www.iimena.org

TOPCAPI - Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients

Financiado por: Comision Europea  - Reference NMBP-BIO-2016 - 720793-2 - Duración: 48 meses

TOPCAPI will exploit the natural biosynthetic potential of actinomycetes as microbial cell factories to produce advanced pharmaceutical ingredients: a new anti-acne drug, in Phase II clinical trials, and three related drugs against multidrug resistant bacteria MRSA, in Phase III clinical trials.  For that purpose, two common microbial bacteria will be characterized using systems biology approaches, applying integrated data analysis to transcriptomics and metabolomics experiments, combined with predictive mathematical modelling to drive the rapid improvement of these microbial cell factories for industrial production of these drugs. At the same time, we will establish a toolbox for future engineering high value advanced pharmaceutical ingredients.

www.topcapi.eu

MARPIPE - Improving the flow in the pipeline of the next generation of marine biodiscovery scientists

Financiado por: Comisión Europea - Referencia MSCA-ITN-ETN - 721421 - Duración 48 meses.

MarPipe is a consortium of 11 partners (IBP-CNR, SZN, UiT, UNIABDN, GEOMAR, KULeuven, UCC, eCOAST, MEDINA, MicroDish, Italbiotec) based in 8 countries (I, N, UK, D, B, IRL, E, NL), including 3 from the non-academic sector. MarPipe aims at further development of antimicrobial and anticancer lead compounds originating from a previous EU project (PharmaSea), and will also explore the bioactivity of deep-sea samples (5000m) collected during the recent Eurofleet-2 project in the sub-Antarctic.

www.marpipe.eu

 

OCEAN MEDICINES - Stimulating innovation by means of cross-fertilisation of knowledge

Financiado por: Comision Europea - Reference: 690944 - H2020-EU.1.3.3. -  01/12/2015 al 30/11/ 2019

Ocean Medicines, a network of academic, research centres and SMEs across Europe, aims to establish a network of collaboration and knowledge-exchange between industrial and academic partners to further develop lead compounds from marine microorganisms having anticancer or anti-infective effects that have already been identified by the consortium.

ocean medicines

 

http://cordis.europa.eu/project/rcn/198834_en.html

logoeu22

Determinación de perfiles metabolómicos en el diagnóstico precoz del cáncer de mama. Implicaciones pronosticas y predictivas de respuesta al tratamiento

Proyecto RETOS

Financiado por Ministerio de economía y competitividad - Proyecto RETOS REF - RTC-2016-5674-1

Participantes y liderado por ALHIA HEALTH: ALTHIA HEALTH, MEDINA, FIBAO

RETOALTHIA

 

 

 

MINCOMP

BLUE AND GREEN - Marine Biotechnology

Financiado por: Comision Europea - Refrence 692419.

BLUEandGREEN aims to increase the performance of CIIMAR in the area of Marine Biotechnology, and joins CIIMAR with four internationally-leading counterparts at the EU level: the University of Helsinki - Finland, the University of Bergen - Norway, GEOMAR, Helmholtz Centre for Ocean Research Kiel – Germany, and Fundación MEDINA - Spain.

bluegreen

 

logoeu22

ENABLE - European Gram Negative Antibacterial Engine

Financiado por: Innovative Medicines Iniciative (IMI)- New Drugs for Bad Bugs ND4BB - Duración 2013-2018

emiepfia

http://www.imi.europa.eu

MICROSMETICS - Exploitation of microbial biodiversity for the discovery and development of novel cosmeceutical agents

Financiado por: European Union FP7-PEOPLE-2013-IAPP - Ref. nº 612276 - Duración 2013-2017

micrsmeticsand co

http://www.microsmetics.eu

logoeu22

Impacto en salud pública de la dispersión de enterobacterias productoras de carbapenemasas en España: Caracterización molecular de las cepas circulantes

Referencia nº PI12/0242 - Duración 2013-2015

isciiipj

http://www.isciii.es

PharmaSea - Value Flow in the Marine Biodiscovery Pipeline

Financiado por: European Union FP7-KBBE-2012-6-singlestage - Ref. nº 312184 - Duration 2012-2015

pharma7th

http://www.pharma-sea.eu

ParaMet - An analysis of parasite metabolism-from metabolism to intervention

Financiado por: European Union FP7-PEOPLE-2011-ITN - Ref. nº 290080 - Duración: 2012-2015

PARAMETEU

http://www.paramet.eu

COCULMICRO - Cocultivation of microorganisms as a strategy for discovery of new natural products with antimicrobial properties

Financiado por: European Union FP7-PEOPLE-2011-CIG Marie Curie Support for Training & Career develoment of researchers - Ref. nº PCIG09-GA-2011-293992 - Duración: 08/2011-07/2015

 

 

http://cordis.europa.eu/project/rcn/99904_en.html

logoeu22

DOSYMNPS - Novel applications of diffusion NMR spectroscopy in microbial natural products research

Financiado por: European Union FP7-PEOPLE-2011-CIG Marie Curie Support for Training & Career develoment of researchers. Ref. nº PCIG09-GA-2011-293762 - Duración: 09/2011-08/2015

http://cordis.europa.eu/project/rcn/99978_en.html

logoeu22

Descubrimiento de nuevos antibicoticos mediante la combinación de dos estrategias: cultivo de bacterias no cultivadas previamente y muestreo de hábitats salinos de Andalucía

Financiado por: Junta de Andalucía. Projecto de Excelencia científica- Ref. nº CTS-5859 - Duración: 2011-2013

 

JUNTA ANDALUCIA

http://www.juntadeandalucia.es

Descubrimiento y desarrollo de nuevos antibióticos frente a bacterias gram negativas multiresistentes y de fármacos potenciadores de la actividad de carpabenems

Financiado por: Junta de andalucía. Projecto de Excelencia científica nº CVI-6909 - Duración: 2011-2013

logo_junta_andalucia

http://www.juntadeandalucia.es

Antibiotics against multiresistant Gram negative pathogens and potentiators of carbapenem activity

Financiado por: Instituto de Salud Carlos III - Ref. nº PI10/00745 - 2011-2013

isciiipj

http://www.isciii.es

 

Use of zebrafish as experimental model: evaluation of mithocondrial disfunction and identification of neuroprotective compounds from microbial natural in collaboration with The University of Granada

Financiado por Junta de Andalucía. Projecto de Excelencia científica - Ref. nº CTS-5784

JUNTAUGR

http://www.juntadeandalucia.es

Equipamiento complementario de alto rendimiento para el aislamiento y caracterización de Productos Naturales Bioactivos

Financiado por: Ministerio de ciencia e Innovación  Ref. INP-2011-0016-PCT-010000-ACT6 - Duración: 2011

ministeriocienciainov

http://www.idi.mineco.gob.es

Discovery and characterization of new antibiotics by culturing previously uncultured bacteria

Financiado por: Ministerio de ciencia e innovación - Ref. nº SAF 2010-15010 - Duración: 2011-2013

ministeriocienciainov

http://www.idi.mineco.gob.es

Búsqueda de Nuevos Antibacterianos y Caractericación de la Librería de Productos Naturales de la Fundación MEDINA

Financiado por: Ministerio de Ciencia e Innovación dentro de los Presupuestos Generales del Estado para el 2010 aplicación presupuestaria 21.03.463B.789.01 / Duration: 2010

ministeriocienciainov

http://www.idi.mineco.gob.es

Discovery and development of pharmaceuticals efficacious for amyotrophic lateral sclerosis (Lou Gerhig´s Disease)

Financiado por: Ministerio de ciencia e Innovación: PPT-300000 - Duración: 2009-2011

ministeriocienciainov

http://www.idi.mineco.gob.es

AntiFun: The cell wall as a target to improve antifungal therapy against Aspergillosis

Financiado por: ERA-NET: Pathogenomics (7th FP) - Duració: 2009-2011

eraneteu

https://www.pathogenomics-era.net

CONSOLIDER-INGENIO 2010: Discovery of novel antimicrobials from the Metagenome of the Iberian Peninsula

Financiado por: Ministerio de ciencia e Innovación - Duración: 2008-2012

ministeriocienciainov

http://www.idi.mineco.gob.es/